REGENERON PHARMACEUTICALS, INC.;UNIVERSITY HEALTH NETWORK (UHN)
发明人:
PURCELL, NGAMBO, LISA, ARLEEN,HIGGINS, SARAH, J.,KAIN, KEVIN, C.
申请号：
RSP20190841
公开号：
RS59000B1
申请日:
2014.10.31
申请国别(地区):
RS
年份:
2019
代理人:
摘要：
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.
